8
4/16/19 1 Medication Management in Diabetes Care: Advanced Faaiza Alibhai, PharmD Endocrine and Diabetes Care Center UW Medicine WADE Conference April 26, 2019 Disclosures to Participants Notice of Requirements for Successful Completion: For successful completion, participants are required to be in attendance in the full activity and complete the program evaluation at the conclusion of the educational event. Presenter Conflicts of Interest/Financial Relationships Disclosures No conflicts exist. Disclosure of Relevant Financial Relationships and Mechanism to Identify and Resolve Conflicts of Interest: No conflicts of interest. Non-Endorsement of Products: Accredited status does not imply endorsement by AADE, ANCC, ACPE or CDR of any commercial products displayed in conjunction with this educational activity. Off-label Use: Participants will be notified by speakers to any product used for a purpose other than that for which it was approved by the Food and Drug Administration.

WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

4/16/19

1

Medication Management in Diabetes Care: Advanced FaaizaAlibhai,PharmDEndocrineandDiabetesCareCenterUWMedicineWADEConferenceApril26,2019

Disclosures to Participants

• NoticeofRequirementsforSuccessfulCompletion:•  Forsuccessfulcompletion,participantsarerequiredtobeinattendanceinthefullactivityandcompletetheprogramevaluationattheconclusionoftheeducationalevent.• PresenterConflictsofInterest/FinancialRelationshipsDisclosures• Noconflictsexist.• DisclosureofRelevantFinancialRelationshipsandMechanismtoIdentifyandResolveConflictsofInterest:Noconflictsofinterest.• Non-EndorsementofProducts:AccreditedstatusdoesnotimplyendorsementbyAADE,ANCC,ACPEorCDRofanycommercialproductsdisplayedinconjunctionwiththiseducationalactivity.• Off-labelUse:ParticipantswillbenotifiedbyspeakerstoanyproductusedforapurposeotherthanthatforwhichitwasapprovedbytheFoodandDrugAdministration.

Page 2: WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

4/16/19

2

Ancient Egypt

TheEbersPapyruscontainsremedies“toeliminateurinewhichistooplentiful”

AmeasuringglassfilledwithWaterfromtheBirdpond,Elderberry,Fibresoftheasitplant,FreshMilk,Beer-Swill,FloweroftheCucumber,andGreenDates

Rectalinjectionsofoliveoil,honey,sweetbeer,seasalt,andseedsofthewonderfruitwerealsousedforurinarytroubles

Indian Ayurveda

InAncientIndia,physiciansnotedantswereattractedtotheurineofpeoplewithmadhumehaor“honeyurine”

Diabetesprimarilyaffectedrichcastes;relatedtoexcessivefoodconsumption

Recommendedabstainingfromsweetfoodsandreducingtheintakeofriceandothergrains

The Greeks and Persians

GreekphysicianAretaeusdubbeddiabetes“meltingdownoffleshandlimbsintourine”

EarlyGreeksrecommendeddrinkinglargequantitiesofwine,thoughttomakeupforfluidlostthroughurination

Alsoprescribedexercise,oftenhorsebackriding,thoughttorelieveexcessiveurination

PersianphysicianAvicennareferredtoabnormalappetiteandobserveddiabeticgangreneandconcoctedamixtureofseeds(lupin,fenugreek,zedoary)asapanacea

Page 3: WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

4/16/19

3

The 18th and 19th Centuries

DuringtheFranco-PrussianWar,FrenchphysicianandpharmacistApollinaireBouchardatnotedthatwar-relatedfoodrationingimproveddiabetessymptoms

Thisledtothefaddiets:- Oatcure-  Potatotherapy-  Starvationdiet-  Ricecure- Opium

ItaliandiabetesspecialistCatonilockeduphispatientstogetthemtofollowtheirspecial,low-carbohydratediets

Turn of the Century

AmericandiabetesspecialistsFrederickM.AllenandElliottP.Joslinadvocatedforseverecalorie-restricteddiets

Priortothe1920’s,adiagnosisofdiabeteswasadeathsentenceformostpatients

19thcenturyresearchidentifiedtheroleofapancreatichormoneinvolvedinglucosehomeostasis.Thisledtoexperimentationwithdogswhosepancreaseshadbeenremoved

The Dawn of a New Era

CanadianphysicianFrederickBanting,assistantCharlesBest,andbiochemistBertramCollipestablishedthatthedeficiencyofinsulinwasthecauseofdiabetesusingcaninepancreaticextracts

LeonardThompsonwasthefirstpatienttoreceiveinsulin

Havingbeenclosetodeath,Leonardlivedforanother13years

Page 4: WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

4/16/19

4

1915 2020

1922-Firstexogenousinsulinadministeredtoa

human

1923-Insulin(Iletin)commercially

availableintheUnitedStates

1936-PZIinsulin

1946-NPHinsulin

1956-Lenteinsulins

1983-Recombinanthumaninsulin

1952-Firstconcentrated

insulins2006–First

inhaledinsulin

Evolution of Insulin

Development of New Classes

1915

1918-Earlyworkwithguanidine

1920s–Synthalinusestopped

1956-FirstcommerciallyavailableSUinUnitedStates

1959-Metforminintroduced(outsideUnited

StatesintroducedtoUnitedStatesin1990s)

1984-SecondgenerationSU

1995-FirstAGI

1996-FirstTZD

1997-Firstmeglitinide

Page 5: WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

4/16/19

5

Development of New Classes Cont.

2020

2005-FirstGLP-1RA

2005-Firstamylinagonist

2006-FirstDPP-4i

2008-colesevelamapprovedfordiabetes

2009-Bromocriptineapprovedfordiabetes

2013-FirstSGLT-2i

MetforminInsulinThiazolidinediones

SodiumGlucoseCotransporter-2Inhibitors

SulfonylureasMeglitinidesGLP-1ReceptorAgonistsDPP-4Inhibitors Thiazolidinediones

MetforminGLP-1ReceptorAgonistsDPP-4Inhibitors

GLP-1ReceptorAgonistsAmylinAgonistsBromocriptine

Metforminα-GlucosidaseInhibitorsColesevelam

GLP-1ReceptorAgonistsDPP-4InhibitorsAmylinAgonists

α-GlucosidaseInhibitorsColesevelam

ADA 2019 Standards of Medical Care in Diabetes

Page 6: WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

4/16/19

6

ADA 2019 Standards of Medical Care in Diabetes

Completed and Ongoing Cardiovascular Outcomes Trials

ADA 2019 Standards of Medical Care in Diabetes

Page 7: WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

4/16/19

7

ADA 2019 Standards of Medical Care in Diabetes

ADA 2019 Standards of Medical Care in Diabetes

ADA 2019 Standards of Medical Care in Diabetes

Page 8: WADE Lecture Final without graphics. Faiiza Alibhai. Updatedwadepage.org/files/2019Conf/WADE Lecture Final without graphics. F… · DPP-4i 2008 - colesevelam approved for diabetes

4/16/19

8

ADA 2019 Standards of Medical Care in Diabetes

AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm 2019